* Q1 EPS 58 cents; Wall St view 49 cents
* Sees FY EPS $2.40-$2.52
NEW YORK, April 30 (Reuters) - Watson Pharmaceuticals WPI.N posted better-than-expected quarterly profit on Thursday, helped by strong performance of its generic drugs, and the company raised its full-year forecast.
First-quarter net income slipped to $49.1 million, or 43 cents per share, from $50.6 million, or 45 cents per share, a year earlier.
Excluding special items, earnings were 58 cents per share, 9 cents ahead of analysts’ average forecast, according to Reuters Estimates.
Revenue rose 6.5 percent to $667.4 million.
Watson forecast full-year earnings, excluding items, of $2.40 to $2.52 per share. It previously forecast $2.18 to $2.28. (Reporting by Lewis Krauskopf; editing by John Wallace)